Dow hits record high on tame inflation report that also boosts small caps
The blue-chip Dow Jones Industrial Average hit a new record high on Friday as investors cheered a tame inflation report that ...
Federal employee health-care premiums to rise 13.5 percent on average
The increase is nearly double last year’s 7.7. percent raise and driven by higher market costs this year, the Office of ...
FDA greenlights Regeneron’s Dupixent for the treatment of COPD
With an approval based on two pivotal Phase III studies, Dupixent is now the first-ever biologic indicated for treating COPD.
A New Era For Kratom: What The Latest FDA Study Reveals About Kratom Leaf
For years, kratom has been clouded by controversy, largely fueled by media portrayals that paint a negative picture of this ...
US FDA lifts clinical hold on Biomea’s diabetes trials after safety review
The drug BMF-219 works by increasing, preserving and reactivating patients’ own healthy insulin-producing cells. Read more at ...
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. BMO Capital analyst notes ...
MM&M57m
Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years
Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.
JD Supra47m
FDA Issues Multiple Guidances Supporting Clinical Trial Innovation
In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...
Expert-Backed Salicylic Acid Cleansers to Suppress Acne and Exfoliate Skin
Refresh your skin and combat breakouts with these top salicylic acid cleansers from Skinbetter, Cetaphil and more.
The 9 Best Salicylic Acid Cleansers for Men in 2024, According to Experts
Refresh your skin and combat breakouts with these top salicylic acid cleansers from Skinbetter, Cetaphil and more.
Buy Rating Affirmed for Biomea Fusion with Promising BMF-219 Clinical and Regulatory Developments
Joseph Pantginis, an analyst from H.C. Wainwright, maintained the Buy rating on Biomea Fusion (BMEA – Research Report). The associated ...
New schizophrenia drug ‘could change the lives of millions of people’
A groundbreaking new drug to treat schizophrenia called Cobenfy, owned by pharmaceutical firm Bristol Myers Squibb, has been ...